Table 2.
Determination of BTH in the stratum corneum using the proposed sensing protocol after 12 h of Butaximark® cream application on the forearm of the volunteer
| Pharmaceutical formulations | Claimed (µM/cm2) | Recovery% ± SD (n = 5) | Standard addition | |
|---|---|---|---|---|
| Amount added (µM) | Recovery% ± SD (n = 5) | |||
| Butaximark® (10 mg of BTH /1gm) | 5.26 | 22.31 | 99.48 | |
| 53.19 | 99.54 | |||
| 72.73 | 101.41 | |||
| 91.48 | 98.13 | |||
| 109.48 | 99.72 | |||
| 126.78 | 99.14 | |||
| Mean ± S.D | 98.47 ± 0.853 | 99.57 ± 1.06 | ||